跳至主要内容
临床试验/JPRN-jRCTs031200290
JPRN-jRCTs031200290已完成1 期

Safety evaluation of intranasal insulin administration during cardiac surgery for preventing postoperative delirium and cognitive dysfunction

Kawakami Akiko0 个研究点目标入组 27 人开始时间: 2021年1月12日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
27

研究概览

简要总结

Intranasal insulin administration 160 unit and less did not cause hypoglycemia. We need further study regarding minor complications.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1)Patients scheduled elective cardiac surgery or major vascular surgery with cardiopulmonary bypass
  • 2)Patients who are 20 years old or older
  • 3)Patients with 1.5 mg/dL or less preoperative creatinine
  • 4)Patients who had not undergone nasal surgery
  • 5)Patients with written consent
  • 6)Patients who are able to communicate with Japanese

排除标准

  • 1 Patients had 23 or less preoperative MMSE score
  • 2 Patients with insulin allergy
  • 3 Patients under mechanical ventilation
  • 4 Patients with severe psychological disorder
  • 5 Patients with severe liver dysfunction
  • 6 Patients with severe infectious diseases
  • 7)Patients with severe cerebral infarction
  • 8)Patients with dyspituitarism or adrenal insufficiency

研究者

发起方
Kawakami Akiko

相似试验